{
"id":"mk19_bb_np_s14",
"subspecialtyId":"np",
"title":"Hypertensive Emergency",
"jsonContent":{
"type":"section",
"id":"mk19_bb_np_s14",
"title":{
"__html":"Hypertensive Emergency"
},
"titleNode":{
"type":"section-title",
"hlId":"72388f",
"children":[
"Hypertensive Emergency"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_np_s14_0",
"children":[
{
"type":"p",
"hlId":"44a5a6",
"children":[
"Hospitalize a patient with hypertensive emergency (",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" ≥180/120 mm Hg and symptoms or evidence of end-organ damage)."
]
},
{
"type":"p",
"hlId":"a9072b",
"children":[
"For a compelling condition (such as aortic dissection, severe preeclampsia or eclampsia, or pheochromocytoma crisis), ",
{
"type":"abbreviation",
"title":"systolic blood pressure",
"children":[
"SBP"
]
},
" should be reduced to <140 mm Hg during the first hour and to <120 mm Hg in aortic dissection."
]
},
{
"type":"p",
"hlId":"894a6f",
"children":[
"Without a compelling condition, SBP should be reduced by no more than 25% within the first hour; then, if stable, reduce to 160/100 mm Hg within the next 2 to 6 hours; finally, cautiously reduce to normal during the following 24 to 48 hours. See Neurology for treatment of hypertension associated with ischemic stroke and intracerebral hemorrhage."
]
},
{
"type":"p",
"hlId":"66465b",
"children":[
"For patients without a compelling indication, treatment consists of short-acting IV drugs administered in the ",
{
"type":"abbreviation",
"title":"intensive care unit",
"children":[
"ICU"
]
},
" (e.g., nitroglycerin, nitroprusside, labetalol, nicardipine)."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_np_s14_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"88c750",
"children":[
"Do not select sublingual nifedipine for either hypertensive urgency or emergency."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_np_s14_inline_t1":{
"id":"mk19_bb_np_s14_inline_t1",
"number":1,
"bookId":"np",
"title":{
"__html":"Study Table: IV Antihypertensive Drugs for Treatment of Hypertensive Emergencies in Patients With a Compelling Comorbidity"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"164020",
"children":[
"Study Table: IV Antihypertensive Drugs for Treatment of Hypertensive Emergencies in Patients With a Compelling Comorbidity"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"15edea",
"class":"col hd l",
"children":[
"Comorbidity"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"336741",
"class":"col hd l",
"children":[
"Preferred Drugs"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30cfdb",
"class":"cell txt l",
"children":[
"Acute aortic dissection"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"43ca97",
"class":"cell txt l",
"children":[
"Esmolol, labetalol"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9bca7a",
"class":"cell txt l",
"children":[
"Acute pulmonary edema"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8329b7",
"class":"cell txt l",
"children":[
"Nitroglycerin, nitroprusside"
]
},
" ",
{
"type":"p",
"hlId":"b2308c",
"class":"cell txt l",
"children":[
"β-Blockers contraindicated"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0a5f1d",
"class":"cell txt l",
"children":[
" ",
{
"type":"abbreviation",
"title":"acute coronary syndrome",
"children":[
"ACS"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"86b4c4",
"class":"cell txt l",
"children":[
"Esmolol, nitroglycerin"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"810726",
"class":"cell txt l",
"children":[
" ",
{
"type":"abbreviation",
"title":"acute kidney injury",
"children":[
"AKI"
]
},
" "
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c61602",
"class":"cell txt l",
"children":[
"Nicardipine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"57be55",
"class":"cell txt l",
"children":[
"Eclampsia or preeclampsia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4badda",
"class":"cell txt l",
"children":[
"Hydralazine, labetalol, nicardipine"
]
},
" ",
{
"type":"p",
"hlId":"85d505",
"class":"cell txt l",
"children":[
{
"type":"abbreviation",
"title":"angiotensin-converting enzyme",
"children":[
"ACE"
]
},
" inhibitors, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"angiotensin receptor blocker",
"children":[
"ARB"
]
},
"s,"
]
},
" renin inhibitors, nitroprusside contraindicated."
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}